The Poland Neurology Device Market is expected to witness growth from $73 Mn in 2022 to $xx Bn in 2030 with a CAGR of xx% for the forecasted year 2022-2030. The neurology devices market in Poland is expanding as a result of factors such as the prevalence of neurological conditions like dementia, Parkinson's disease, and stroke is rising in Poland as the population ages. As a result, the demand for neurology devices is rising. The market is segmented by product type and by the end user. Some key players in this market include Synektik, Skamex, Medtronic, Abbott Laboratories, GE Healthcare, Penumbra, and Boston Scientific.
The Poland neurology devices market size is at around $73 Mn in 2022 and is projected to reach $xx Bn in 2030, exhibiting a CAGR of xx% during the forecast period. Poland has some of the lowest health spending in the European Union (EU). Compared to the average for the EU, which was $2975.89, or 9.9% of GDP, in 2015, health spending was $1347.23 per capita, or 6.3% of GDP. 72% of expenditures come from public funds, which is less than the EU average of 79%. Concerns about accessibility are raised by the relatively high (22%) out-of-pocket spending. In Poland, the percentage of adults who smoke every day decreased from 28% in 2001 to 23% in 2014, however, it is still higher than in the majority of European Union (EU) countries.
In Poland, stroke, dementia, epilepsy, multiple sclerosis, Parkinson's disease, and headache disorders are the most prevalent neurological illnesses. A number of variables, including age, gender, lifestyle, environmental factors, and genetic factors, affect the incidence and prevalence of these diseases. In Poland, stroke is the main cause of death and disability, accounting for 50–60 cases per 100,000 people annually. Meanwhile, roughly 6% of Poles over the age of 65 are affected by dementia, which is a serious public health concern. Epilepsy affects roughly 1% of the population in Poland, while multiple sclerosis affects around 25,000 people. Parkinson's disease is expected to afflict roughly 1-2% of the people over the age of 60 in Poland. Neurology devices have several uses besides just diagnosis and therapy. For instance, they are employed in studies to better comprehend neurological problems and create fresh therapies. To aid patients in recovering from stroke or other neurological injuries, they are also applied in rehabilitation settings.
Market Growth Drivers
The market is anticipated to expand as Poland's demand for neurology devices increases. The prevalence of neurological conditions like dementia, Parkinson's disease, and stroke is rising in Poland as the population ages. As a result, the demand for neurology devices is rising. New and enhanced neurology devices that are more precise, efficient, and user-friendly have been created as a result of technological advancements. One such example is the ability to treat neurological problems without surgery or other invasive treatments thanks to the development of non-invasive technology like Transcranial Magnetic Stimulation (TMS) and neurostimulation devices.
Market Restraints
Poland's market for neurology devices is quite cutthroat, with numerous manufacturers contending for market dominance. It may be challenging for new competitors to gain traction and for well-established businesses to hold onto market share as a result. It can be difficult and expensive to obtain regulatory approval for innovative neurological devices in Poland due to the country's complex regulatory framework. This may prevent new producers from entering the market and hinder market innovation.
Key Players
2021: In order to provide enhanced monitoring, defibrillation, and resuscitation solutions, Remote Diagnostic Technologies (RDT), a Poland company, has been acquired by Philips.
The key regulatory agency in Poland in charge of approving medical devices is the Polish Agency for Medical Devices (PAM). Prior to being marketed in Poland, PAM is in charge of making sure that all neurology devices adhere to the necessary safety and efficacy requirements. Neurology devices must be registered with Polish Agency for Medical Devices (PAM) in order to be sold in Poland. A thorough application that contains details about the device's design, intended usage, and clinical evidence proving its usefulness must be submitted as part of the registration procedure. Poland's National Health Fund (NFZ) is in charge of paying reimbursements for neurology devices. Neurology devices must fulfill specific requirements, such as having a CE mark and being listed on the NFZ's list of reimbursed devices, in order to be eligible for payment.
1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
The Neurology Device Market is segmented as mentioned below:
By Product Type (Revenue, USD Billion):
By End User (Revenue, USD Billion):
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.